<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="neoplasia"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3556942/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556942/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Neoplasia (New York, N.Y.)"><meta name="citation_title" content="Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
"><meta name="citation_authors" content="Guangfu Jin, Siqun Lilly Zheng, Hans Lilja, Seong-Tae Kim, Sha Tao, Zhengrong Gao, Tracey Young, Fredrik Wiklund, Junjie Feng, William B Isaacs, Roger S Rittmaster, Henrik Gronberg, Lynn D Condreay, Jielin Sun, Jianfeng Xu"><meta name="citation_date" content="January 2013"><meta name="citation_issue" content="1"><meta name="citation_volume" content="15"><meta name="citation_firstpage" content="95"><meta name="citation_doi" content="10.1593/neo.121620"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3556942/?report=abstract"><meta name="citation_pmid" content="23359319"><meta name="DC.Title" content="Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Neoplasia Press"><meta name="DC.Contributor" content="Guangfu Jin"><meta name="DC.Contributor" content="Siqun Lilly Zheng"><meta name="DC.Contributor" content="Hans Lilja"><meta name="DC.Contributor" content="Seong-Tae Kim"><meta name="DC.Contributor" content="Sha Tao"><meta name="DC.Contributor" content="Zhengrong Gao"><meta name="DC.Contributor" content="Tracey Young"><meta name="DC.Contributor" content="Fredrik Wiklund"><meta name="DC.Contributor" content="Junjie Feng"><meta name="DC.Contributor" content="William B Isaacs"><meta name="DC.Contributor" content="Roger S Rittmaster"><meta name="DC.Contributor" content="Henrik Gronberg"><meta name="DC.Contributor" content="Lynn D Condreay"><meta name="DC.Contributor" content="Jielin Sun"><meta name="DC.Contributor" content="Jianfeng Xu"><meta name="DC.Date" content="2013 Jan"><meta name="DC.Identifier" content="10.1593/neo.121620"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
"><meta property="og:type" content="article"><meta property="og:description" content="Percentage of free-to-total prostate-specific antigen (%fPSA) is an independent predictor of risk for prostate cancer among men with modestly elevated level of total PSA (tPSA) in blood. Physiological and pathological factors have been shown to influence ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556942/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-neoplasia.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3556942/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3556942/pdf/neo1501_0095.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8D143EDD54CD810000000008760597.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556942%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="mesh" class="last">MeSH</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/367/">Neoplasia</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/218853/">v.15(1); 2013 Jan</a></li><li class="accid">PMC3556942</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-neoplasia.gif" alt="Logo of neoplasia" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,30,118,50" alt="Guide for Authors" title="Guide for Authors" href="http://www.elsevier.com/journals/Neoplasia/1476-5586/guide-for-authors" ref="reftype=publisher&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="118,30,165,50" alt="About this journal" title="About this journal" href="http://www.journals.elsevier.com/Neoplasia" ref="reftype=publisher&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="165,30,286,50" alt="Explore this journal" title="Explore this journal" href="http://www.sciencedirect.com/science/journal/14765586" ref="reftype=publisher&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="Neoplasia (New York, N.Y.)" title="Neoplasia (New York, N.Y.)" href="http://www.neoplasia.com" ref="reftype=publisher&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Neoplasia</a></span>. 2013 Jan; 15(1): 95–101. </span></div><div>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1593%2Fneo.121620" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1593/neo.121620</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3556942</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23359319">23359319</a></div></div></div></div><h1 class="content-title">Genome-wide Association Study Identifies Loci at <em>ATF7IP</em> and <em>KLK2</em> Associated with Percentage of Circulating Free PSA<sup><a href="#FN1" rid="FN1" class=" fn">1</a></sup>
<sup><a href="#FN2" rid="FN2" class=" fn">2</a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Jin%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771017352976" co-class="co-affbox">Guangfu Jin</a>,<sup>*</sup><sup>†,</sup><sup>3</sup> <a href="/pubmed/?term=Zheng%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771012193344" co-class="co-affbox">Siqun Lilly Zheng</a>,<sup>*</sup><sup>†,</sup><sup>3</sup> <a href="/pubmed/?term=Lilja%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771019852688" co-class="co-affbox">Hans Lilja</a>,<sup>‡</sup><sup>§</sup> <a href="/pubmed/?term=Kim%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771013474624" co-class="co-affbox">Seong-Tae Kim</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Tao%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771013471904" co-class="co-affbox">Sha Tao</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Gao%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771020137328" co-class="co-affbox">Zhengrong Gao</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Young%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771017230112" co-class="co-affbox">Tracey Young</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Wiklund%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771015755680" co-class="co-affbox">Fredrik Wiklund</a>,<sup>‡</sup><sup>§</sup> <a href="/pubmed/?term=Feng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771011517312" co-class="co-affbox">Junjie Feng</a>,<sup>*</sup><sup>†</sup> <a href="/pubmed/?term=Isaacs%20WB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771014433680" co-class="co-affbox">William B Isaacs</a>,<sup>¶</sup> <a href="/pubmed/?term=Rittmaster%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771014431696" co-class="co-affbox">Roger S Rittmaster</a>,<sup>#</sup> <a href="/pubmed/?term=Gronberg%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771014726608" co-class="co-affbox">Henrik Gronberg</a>,<sup>**</sup> <a href="/pubmed/?term=Condreay%20LD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771020879440" co-class="co-affbox">Lynn D Condreay</a>,<sup>††</sup> <a href="/pubmed/?term=Sun%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771020877456" co-class="co-affbox">Jielin Sun</a>,<sup>*</sup><sup>†</sup> and  <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319" class="affpopup" co-rid="_co_idm139771019101088" co-class="co-affbox">Jianfeng Xu</a><sup>*</sup><sup>†</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139771017352976"><h3 class="no_margin">Guangfu Jin</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Jin%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Guangfu Jin</a></div></div><div id="_co_idm139771012193344"><h3 class="no_margin">Siqun Lilly Zheng</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Zheng%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Siqun Lilly Zheng</a></div></div><div id="_co_idm139771019852688"><h3 class="no_margin">Hans Lilja</h3><p><sup>‡</sup>Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY</p><p><sup>‡</sup>Department of Laboratory Medicine in Malmo, Lund University, Skane University Hospital, Malmo, Sweden</p><div>Find articles by <a href="/pubmed/?term=Lilja%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Hans Lilja</a></div></div><div id="_co_idm139771013474624"><h3 class="no_margin">Seong-Tae Kim</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Kim%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Seong-Tae Kim</a></div></div><div id="_co_idm139771013471904"><h3 class="no_margin">Sha Tao</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Tao%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Sha Tao</a></div></div><div id="_co_idm139771020137328"><h3 class="no_margin">Zhengrong Gao</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Gao%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Zhengrong Gao</a></div></div><div id="_co_idm139771017230112"><h3 class="no_margin">Tracey Young</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Young%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Tracey Young</a></div></div><div id="_co_idm139771015755680"><h3 class="no_margin">Fredrik Wiklund</h3><p><sup>‡</sup>Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY</p><p><sup>‡</sup>Department of Laboratory Medicine in Malmo, Lund University, Skane University Hospital, Malmo, Sweden</p><div>Find articles by <a href="/pubmed/?term=Wiklund%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Fredrik Wiklund</a></div></div><div id="_co_idm139771011517312"><h3 class="no_margin">Junjie Feng</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Feng%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Junjie Feng</a></div></div><div id="_co_idm139771014433680"><h3 class="no_margin">William B Isaacs</h3><p><sup>¶</sup>Johns Hopkins Medical Institutions, Baltimore, MD</p><div>Find articles by <a href="/pubmed/?term=Isaacs%20WB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">William B Isaacs</a></div></div><div id="_co_idm139771014431696"><h3 class="no_margin">Roger S Rittmaster</h3><p><sup>#</sup>Oncology Development, GlaxoSmithKline, Research Triangle Park, NC</p><div>Find articles by <a href="/pubmed/?term=Rittmaster%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Roger S Rittmaster</a></div></div><div id="_co_idm139771014726608"><h3 class="no_margin">Henrik Gronberg</h3><p><sup>**</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Gronberg%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Henrik Gronberg</a></div></div><div id="_co_idm139771020879440"><h3 class="no_margin">Lynn D Condreay</h3><p><sup>††</sup>Genetics, GlaxoSmithKline, Research Triangle Park, NC</p><div>Find articles by <a href="/pubmed/?term=Condreay%20LD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Lynn D Condreay</a></div></div><div id="_co_idm139771020877456"><h3 class="no_margin">Jielin Sun</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Sun%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Jielin Sun</a></div></div><div id="_co_idm139771019101088"><h3 class="no_margin">Jianfeng Xu</h3><p><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</p><p><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</p><div>Find articles by <a href="/pubmed/?term=Xu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23359319">Jianfeng Xu</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139771022222880_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139771022222880_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139771022222880_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139771022222880_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>*</sup>Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC</div><div class="fm-affl" id="A2" lang="en"><sup>†</sup>Department of Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC</div><div class="fm-affl" id="A3" lang="en"><sup>‡</sup>Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY</div><div class="fm-affl" id="A4" lang="en"><sup>‡</sup>Department of Laboratory Medicine in Malmo, Lund University, Skane University Hospital, Malmo, Sweden</div><div class="fm-affl" id="A5" lang="en"><sup>¶</sup>Johns Hopkins Medical Institutions, Baltimore, MD</div><div class="fm-affl" id="A6" lang="en"><sup>#</sup>Oncology Development, GlaxoSmithKline, Research Triangle Park, NC</div><div class="fm-affl" id="A7" lang="en"><sup>**</sup>Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden</div><div class="fm-affl" id="A8" lang="en"><sup>††</sup>Genetics, GlaxoSmithKline, Research Triangle Park, NC</div><div id="idm139771014326688">Address all correspondence to: Dr Jianfeng Xu or Dr Jielin Sun, Center for Cancer Genomics, Medical Center Blvd, Winston-Salem, NC 27157. E-mail: <a href="mailto:dev@null" data-email="ude.htlaehekaw@uxj" class="oemail">ude.htlaehekaw@uxj</a>, <a href="mailto:dev@null" data-email="ude.htlaehekaw@nusij" class="oemail">ude.htlaehekaw@nusij</a></div><div id="FN3"><sup>3</sup>These authors contributed equally to this work.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139771022222880_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Sep 27; Revised 2012 Nov 15; Accepted 2012 Nov 15.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139771022222880_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  © 2013 Neoplasia Press, Inc. All rights reserved</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3556942/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Figures and Tables</div><div><a href="/pmc/articles/PMC3556942/bin/neo1501_0095SD1.pdf" data-ga-action="click_feat_suppl">neo1501_0095SD1.pdf</a><span style="color:gray"> (148K)</span></div><div class="small guid">GUID:&nbsp;0809988E-4451-4458-8A70-1E58C21336BF</div></div></dd></dl></div><div id="idm139771022208688" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139771022208688title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">Percentage of free-to-total prostate-specific antigen (%fPSA) is an independent predictor of risk for prostate cancer among men with modestly elevated level of total PSA (tPSA) in blood. Physiological and pathological factors have been shown to influence the %fPSA value and diagnostic accuracy.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Materials/Methods</h3><p id="__p3" class="p p-first-last">To evaluate genetic determinants of %fPSA, we conducted a genome-wide association study of serum %fPSA by genotyping 642,584 single nucleotide polymorphisms (SNPs) in 3192 men of European ancestry, each with a tPSA level of 2.5 to 10 ng/ml, that were recruited in the REduction by DUtasteride of Prostate Cancer Events study. Single nucleotide polymorphisms (SNPs) with <em>P</em> &lt; 10<sup>-5</sup> were further evaluated among the controls of a population-based case-control study in Sweden (2899 prostate cancer cases and 1722 male controls), including 464 controls having tPSA levels of 2.5 to 10 ng/ml.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">We identified two loci that were associated with %fPSA at a genome-wide significance level (<em>P</em> &lt;5 x 10<sup>-8</sup>). The first associated SNP was rs3213764 (<em>P</em> = 6.45 x 10<sup>-10</sup>), a nonsynonymous variant (K530R) in the <em>ATF7IP</em> gene at 12p13. This variant was also nominally associated with tPSA (<em>P</em> = .015). The second locus was rs1354774 (<em>P</em> = 1.25 x 10<sup>-12</sup>), near <em>KLK2</em> at 19q13, which was not associated with tPSA levels, and is separate from the rs17632542 locus at <em>KLK3</em> that was previously associated with tPSA levels and prostate cancer risk. Neither rs3213764 nor rs1354774 was associated with prostate cancer risk or aggressiveness.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusions</h3><p id="__p5" class="p p-first-last">These findings demonstrate that genetic variants at <em>ATF7IP</em> and <em>KLK2</em> contribute to the variance of %fPSA.</p></div></div></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Introduction</h2><p id="__p6" class="p p-first">Serum prostate-specific antigen (PSA) test is widely used for prostate cancer screening before diagnosis in Western countries. The introduction of PSA screening for prostate cancer has considerably increased the detection of early-stage cancer. The results from large randomized trials show that PSA-based screening reduces prostate cancer mortality among men who would not otherwise be screened in Europe [<a href="#R1" rid="R1 R2" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1,2</a>], and which has not been feasible to evaluate in the United States [<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751144" role="button" aria-expanded="false" aria-haspopup="true">3</a>]. As a consequence of PSA screening, overdiagnosis and complications of treatment for prostate cancer, including urinary, sexual, and bowel dysfunction, have also been a concern [<a href="#R4" rid="R4 R5" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">4,5</a>]. Nevertheless, serum PSA levels are currently still the most important noninvasive indicator for the emergence and progression of prostate cancer.</p><p id="__p7">Although the PSA level in blood is strongly associated both with risk of diagnosis and long-term outcome of prostate cancer, it has low to modest specificity for prostate cancer diagnosis at a modestly elevated PSA level in blood [<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751141" role="button" aria-expanded="false" aria-haspopup="true">6</a>]. Most of the abnormally elevated PSA results are false positives in terms of prostate cancer. For example, 75% of men with PSA levels in the range of 4.0 to 10 ng/ml have a negative prostate biopsy. In contrast, about 15% of men whose PSA levels were &lt;4.0 ng/ml, have prostate cancer on biopsy [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751145" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. Importantly, about 15% of these cancers detected at a PSA &lt; 4.0 ng/ml were also shown to be high-grade disease and, as such, are likely to progress [<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751148" role="button" aria-expanded="false" aria-haspopup="true">7</a>]. To improve the diagnostic performance of the PSA test, numerous approaches have been proposed, including measuring PSA velocity (change over time), levels of free and protein-bound PSA, PSA density (the PSA level divided by the prostate volume), and the use of cutoff values for PSA levels that are specific to the individual's age, race, or ethnic group [<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751136" role="button" aria-expanded="false" aria-haspopup="true">8</a>].</p><p id="__p8" class="p p-last">Levels of free PSA (fPSA) can be detected and compared to total PSA (tPSA), yielding the percentage of fPSA (%fPSA, also known as ratio PSA). Using %fPSA can improve specificity over tPSA alone, especially in men with intermediate levels of serum PSA, and reduce the proportion of unnecessary biopsies [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751139" role="button" aria-expanded="false" aria-haspopup="true">9</a>]. %fPSA has already been used as an assisting clinical parameter in the screening and diagnosis of prostate cancer for men with intermediate tPSA levels. However, physiological and pathological factors, including hereditary factors, have been shown to influence %fPSA value and diagnostic accuracy [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751151" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. To date, the exact genetic determinants of %fPSA are largely unknown. We now report on a genome-wide association study (GWAS) and replication study among men with intermediate PSA levels, to identify genetic variants associated with %fPSA and to assess their relationship with prostate cancer risk.</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">Materials and Methods</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Study Subjects for GWAS and Replication Stage</h3><p id="__p9" class="p p-first">For the GWAS portion of our study, we utilized samples collected from subjects that were previously recruited for the REduction by DUtasteride of Prostate Cancer Events (REDUCE) study. Details of the REDUCE study design and implementation have been described elsewhere [<a href="#R11" rid="R11 R12" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">11,12</a>]. Briefly, the REDUCE study is a multicenter, randomized, double-blind, placebo-controlled clinical trial, which was designed to evaluate the clinical value of Dutasteride at a dose of 0.5 mg daily, a dual 5α-reductase inhibitor, in reducing the risk of incident prostate cancer. Of 3239 men of European descent who consented for genetic studies in REDUCE (<a href="#SD1" rid="SD1" class=" supplementary-material">Table W1</a>), 3206 subjects having a baseline tPSA level between 2.5 and 10 ng/ml were used for the GWAS of %fPSA. For analysis of associations between single nucleotide polymorphisms (SNPs) and prostate cancer risk, the study subjects were restricted to the placebo group using case and non-case status after 4 years of follow-up (410 of 1654 men in the placebo group developed prostate cancer within this follow-up period). Among these 410 incident prostate cancer patients, associations of SNPs with aggressive disease were further examined by defining aggressiveness as men (<em>n</em> = 124) who developed prostate cancer with a Gleason score of 7 or higher, stage T3b or higher, and/or were lymph node or metastasis positive (N<sup>+</sup> or M<sup>+</sup>, respectively).</p><p id="__p10">The replication study subjects were from a population-based case-control study in Sweden, termed Cancer Prostate in Sweden (CAPS). The study sample was described in detail elsewhere [<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751142" role="button" aria-expanded="false" aria-haspopup="true">13</a>]. In brief, prostate cancer patients were identified between July 2001 and October 2003 and recruited from four of the six regional cancer registries in Sweden and the National Prostate Cancer Register. Control subjects were randomly selected from the Swedish Population Registry, without a diagnosis of prostate cancer, by frequency matching to the cases on age (groups of 5-year intervals) and geographic region. DNA samples from blood were available for 2899 patients and 1722 control subjects after informed consent. As shown in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W1</a>, 464 control subjects with a tPSA level in the range of 2.5 to 10 ng/ml were used for the replication study to confirm GWAS results of %fPSA in REDUCE. In the CAPS case-control study, 2899 cases and 1722 controls were employed to evaluate the association of SNPs with prostate cancer risk. Associations of SNPs with prostate cancer aggressiveness were tested in a case-only study including 1231 aggressive and 1619 nonaggressive cases. Patients were classified as having aggressive disease if their tumors had a clinical stage of T3/T4, N+, M+, Gleason score of 8 or higher, or a serum PSA level of &gt;50 ng/ml; otherwise, the patients were classified as nonaggressive cases.</p><p id="__p11" class="p p-last">The study was approved by the research ethical committees of the Karolinska Institute, Umea University, and Wake Forest University School of Medicine.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Measurement of tPSA and fPSA Levels</h3><p id="__p12" class="p p-first-last">In REDUCE, serum levels of tPSA and fPSA were determined with an enzyme immunoassay at Quest Diagnostics (Van Nuys, CA and Heston, Middlesex, United Kingdom). In CAPS, the levels of tPSA and fPSA in EDTA-anticoagulated plasma were measured in the laboratory of Dr Hans Lilja in the Department of Laboratory Medicine, Lund University, Skane University Hospital (Malmo, Sweden). A dual-label assay (DELFIA Prostatus PSA F/T; PerkinElmer Life Science, Waltham, MA) [<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751152" role="button" aria-expanded="false" aria-haspopup="true">14</a>] was used to simultaneously measure fPSA and tPSA.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Genotyping and Imputation for GWAS in REDUCE</h3><p id="__p13" class="p p-first">GWAS genotyping was performed on the Illumina HumanOmni-Express BeadChip platform at the Center for Cancer Genomics, Wake Forest University School of Medicine. A total of 729,755 SNPs were genotyped in 3225 samples (14 samples were not genotyped because of poor DNA quality). All of the samples had a genome-wide call rate of ≥95% with an overall call rate of 99.7%. After excluding 33 individuals with tPSA levels less than 2.5 ng/ml or more than 10 ng/ml, 3192 subjects were included in the GWAS analysis. The following quality control (QC) criteria were used to exclude SNPs from further analysis: minor allele frequency (MAF) &lt; 0.01 (<em>n</em> = 75,170), genotype call rate &lt; 95% (<em>n</em> = 6961), and P &lt; .001 (<em>n</em> = 8589) for the Hardy-Weinberg Equilibrium test. After exclusions, genotype data on 642,584 SNPs were used for the final genome-wide association analysis.</p><p id="__p14" class="p p-last">Using the combined data of the 1000 Genomes low-coverage pilot project and HapMap3 data as reference haplotype maps, imputation was performed to infer genotypes of SNPs that were not genotyped by the IMPUTE computer program [<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751143" role="button" aria-expanded="false" aria-haspopup="true">15</a>]. A posterior probability of &gt;0.90 was applied to call imputed genotypes. The same QC procedures for genotyped SNPs were also applied to imputed SNPs.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">SNP Selection and Genotyping for Replication in CAPS Samples</h3><p id="__p15" class="p p-first-last">SNPs associated with %fPSA with a P value less than 1 x 10<sup>-5</sup> were selected as candidate loci for replication. The SNPs with the lowest <em>P</em> values among multiple SNPs in linkage disequilibrium (LD) at an <em>r</em><sup>2</sup> &gt; 0.50 were chosen to be genotyped in CAPS samples. As shown in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W2</a>, a total of five SNPs were genotyped in CAPS samples. Genotyping was performed using the MassARRAY iPLEX (Sequenom, Inc, San Diego, CA) at the Center for Cancer Genomics, Wake Forest University. Duplicates and negative controls were included in each 384-well plate to ensure QC. Genotyping was performed by technicians blinded to sample status. The average concordance rate was &gt;98%.</p></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title">Statistical Analysis</h3><p id="__p16" class="p p-first">A linear regression model was used to analyze the association of each SNP with quantitative traits, assuming an additive genetic model, which was implemented in the PLINK software package. Quantitative associations of %fPSA and tPSA were performed after log transformation to limit potential bias because of deviation from normality. We estimated the population stratification using a principal component approach implemented by EIGENSTRAT software [<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751149" role="button" aria-expanded="false" aria-haspopup="true">16</a>]. A common <em>P</em> of 5 x 10<sup>-8</sup> was used as a cutoff for genome-wide significance. For the regions that met the statistical criteria of genome-wide association with %fPSA, ungenotyped SNPs were then imputed and conditional analysis was then applied to test the independence of SNPs, using the originally significant SNPs as covariates for the subsequent analysis. The effects of identified SNPs on prostate cancer risk or aggressiveness were further evaluated in the placebo group of REDUCE and in the case controls of CAPS using logistic regression models.</p><p id="__p17" class="p p-last">We adopted the methods reported by Gudmundsson et al. [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_321246781" role="button" aria-expanded="false" aria-haspopup="true">17</a>] to calculate a personalized %fPSA cutoff value corresponding to the commonly used uniform cutoff of 25%. In brief, this was done by multiplying the value of 25%with the estimated relative genetic effect for the two %fPSA associated SNPs (rs3213764 and rs1354774). Personalized cutoff values for PSA were calculated for each subject. First, a linear regression model was fitted where log transformed %fPSA were treated as outcomes and the number of alleles associated with higher level of biomarkers was treated as a covariate. Genetic effects were calculated for noncarriers (aa), one carrier (Aa), and two carriers (AA) of the allele associated with elevated values, using the fitted values. Relative allelic effects (% of increase per allele) were calculated by dividing the fitted values of aa and Aa. The relative risk to the population for each of the three genotypes (aa, Aa, and AA) were then computed on the basis of the relative allelic effect and genotypic frequency. Second, assuming a multiplicative model, the combined genetic relative effect was calculated by multiplying the relative genotypic effects for each SNP relative to the general population. Third, the personalized cutoff of %fPSA was generated by multiplying a uniform cutoff (i.e., 25%) by the combined genetic relative effect for each subject.</p></div></div><div id="__sec12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title">Results</h2><p id="__p18" class="p p-first">After QC filters, a total of 642,584 genotyped SNPs were analyzed for association with %fPSA among 3192 individuals who had a tPSA level between 2.5 and 10 ng/ml. Principal component analysis showed that all of the subjects were clustered around European descent, and the quantile-quantile (Q-Q) plot showed no obvious evidence of genetic stratification among subjects (genomic inflation factor λ = 1.009; <a href="#SD1" rid="SD1" class=" supplementary-material">Figure W1</a>). Thus, the reported <em>P</em> values are not corrected for genomic inflation. Throughout the genome (<a href="/pmc/articles/PMC3556942/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>), two signals, one at 19q13 (<em>P</em> = 7.39 x 10<sup>-11</sup> and 7.90 x 10<sup>-11</sup> for rs1354774 and rs16987929, respectively) and another at 12p13 (<em>P</em> = 1.85 x 10<sup>-8</sup> for rs3213764), were associated with %fPSA at a genome-wide significance level (<em>P</em> &lt; 5 x 10<sup>-8</sup>). These lead SNPs, rs16987929 and rs1354774 at 19q13, are in moderate LD (<em>r</em><sup>2</sup> = 0.591).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3556942/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139771055594208" class="figure"><a href="/pmc/articles/PMC3556942/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3556942_neo1501_0095_fig001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is neo1501_0095_fig001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3556942/bin/neo1501_0095_fig001.jpg"></a></div><div id="largeobj_idm139771055594208" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3556942/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3556942/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p32">Manhattan plot of the strength of associations (-log<sub>10</sub> (<em>P</em>) values; Y-axis) between SNPs (<em>X</em>-axis by chromosome and chromosomal position) and %fPSA.</p></div></div></div><p id="__p19">The most significant SNP at each locus that was associated with % fPSA with a <em>P</em> value less than 1 x 10<sup>-5</sup> at the GWAS stage was then fast-tracked for further genotyping in a replication analysis using an independent sample set consisting of 464 control subjects with tPSA levels between 2.5 and 10 ng/ml in CAPS. Among these five SNPs, two were also consistently associated with %fPSA in the replication among CAPS controls, with intermediate tPSA levels (2.5–10 ng/ml; rs3213764 at 12p13: <em>P</em> = 9.65 x 10<sup>-3</sup>; and rs1354774 at 19q13: <em>P</em> = 4.71 x 10<sup>-3</sup>; <a href="#SD1" rid="SD1" class=" supplementary-material">Tables W2</a> and <a href="/pmc/articles/PMC3556942/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and1).</span></span><span>1</span></a>). After pooling the GWAS and replication results, we observed a genome-wide significant association of rs3213764 (<em>P</em> = 6.45 x 10<sup>-10</sup>) and rs1354774 (<em>P</em> = 1.25 x 10<sup>-12</sup>) with %fPSA (<a href="/pmc/articles/PMC3556942/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). When we extended the replication analysis to all controls of the CAPS study population (<a href="#SD1" rid="SD1" class=" supplementary-material">Table W3</a>), a more significant association was observed between rs1354774 and %fPSA (<em>P</em> = 1.05 x 10<sup>-11</sup>), resulting in a combined P value of 6.48 x 10<sup>-20</sup>. For association between rs3213764 and %fPSA, similar results were observed between controls with intermediate tPSA levels and all of the controls in CAPS (<em>P</em><sub>combined</sub> = 1.97 x 10<sup>-9</sup>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p34">Summary Results for SNPs Associated with %fPSA at Genome-Wide Significance Level (<em>P</em> 5 x 10<sup>-8</sup>).</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139771010099504" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><td rowspan="1" colspan="1">Chromosome</td><td rowspan="1" colspan="1">SNP</td><td rowspan="1" colspan="1">Gene (Location)</td><td rowspan="1" colspan="1">Stage</td><td rowspan="1" colspan="1">MAF</td><td rowspan="1" colspan="1">Mean<sup>*</sup></td><td rowspan="1" colspan="1"><em>β</em></td><td rowspan="1" colspan="1">SE</td><td rowspan="1" colspan="1"><em>P</em><sup>†</sup></td><td rowspan="1" colspan="1"><em>P</em><sub>combined</sub><sup>‡</sup></td></tr></thead><tbody><tr><td rowspan="1" colspan="1">12p13</td><td rowspan="1" colspan="1">rs3213764 (A/G)<sup>§</sup></td><td rowspan="1" colspan="1"><em>ATF7IP</em> (K530R)</td><td rowspan="1" colspan="1">GWAS (<em>N</em> = 3192)</td><td rowspan="1" colspan="1">0.467</td><td rowspan="1" colspan="1">15.73/16.61/17.34</td><td rowspan="1" colspan="1">0.049</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1">1.85 x 10<sup>-8</sup></td><td rowspan="1" colspan="1">6.45 x 10<sup>-10</sup></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Replication (<em>N</em> = 464)</td><td rowspan="1" colspan="1">0.504</td><td rowspan="1" colspan="1">23.85/26.22/27.15</td><td rowspan="1" colspan="1">0.065</td><td rowspan="1" colspan="1">0.025</td><td rowspan="1" colspan="1">9.65 x 10<sup>-3</sup></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">19q13</td><td rowspan="1" colspan="1">rs1354774 (A/G)<sup>§</sup></td><td rowspan="1" colspan="1"><em>KLK2</em> (∼9 kb at 3′-flank)</td><td rowspan="1" colspan="1">GWAS (<em>N</em> = 3192)</td><td rowspan="1" colspan="1">0.343</td><td rowspan="1" colspan="1">15.64/17.14/17.45</td><td rowspan="1" colspan="1">0.058</td><td rowspan="1" colspan="1">0.009</td><td rowspan="1" colspan="1">7.39 x 10<sup>-11</sup></td><td rowspan="1" colspan="1">1.25 x 10<sup>-12</sup></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Replication (<em>N</em> = 464)</td><td rowspan="1" colspan="1">0.309</td><td rowspan="1" colspan="1">23.98/27.82/27.05</td><td rowspan="1" colspan="1">0.075</td><td rowspan="1" colspan="1">0.026</td><td rowspan="1" colspan="1">4.71 x 10<sup>-3</sup></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm139771010099504" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3556942/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF1"><sup>*</sup>Mean values of %fPSA (%) by genotypes (major homozygote/heterozygote/minor homozygote).</div><div id="TF2"><sup>†</sup><em>P</em> values were from linear regression models adjusted for age.</div><div id="TF3"><sup>‡</sup><em>P</em> values were estimated using inverse variance-weighted meta-analyses according to regression coefficients (<em>β</em>) and corresponding SEs across studies.</div><div id="TF4"><sup>§</sup>Major/minor allele.</div></div></div><p id="__p20">We imputed ungenotyped SNPs at 12p13 in a 300-kb window and tested their associations with %fPSA (<a href="/pmc/articles/PMC3556942/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2<em>A</em></span></a>). The SNPs with <em>P</em> &lt; 10<sup>-5</sup> are presented in <a href="#SD1" rid="SD1" class=" supplementary-material">Table W4</a>, all of which are located within a 210-kb region of LD, incorporating the entire <em>ATF7IP</em> gene and 3′-end of the <em>PLBD1</em> gene. The most significant SNP was rs3213764, a missense variant at codon 530 of the <em>ATF7IP</em> gene. This was the only SNP at 12p13 that showed a genome-wide significant association with %fPSA. There were no other SNPs at 12p13 that were associated with %fPSA at <em>P</em> &lt; .01 after conditioning on rs3213764.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3556942/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139771014128864" class="figure"><a href="/pmc/articles/PMC3556942/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3556942_neo1501_0095_fig002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is neo1501_0095_fig002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3556942/bin/neo1501_0095_fig002.jpg"></a></div><div id="largeobj_idm139771014128864" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3556942/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3556942/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p33">Regional plots of the associations between 12p13 (A) and 19q13 (B) and %fPSA. Associations of individual SNPs have been plotted as -log<sub>10</sub>
<em>P</em> against the chromosomal position. Results of both genotyped and imputed SNPs are shown. Colors indicate the LD strength between themost significant SNPs (shown at the top of each plot with a point in purple) and the other SNPs assessed. The right Y-axis shows the recombination rate estimated from the 1000 Genomes Utah residents with Northern and Western European ancestry (CEU) population.</p></div></div></div><p id="__p21">For chromosome 19q13, imputation was performed within a 200-kb window. As shown in <a href="/pmc/articles/PMC3556942/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2<em>B</em></span></a>, multiple SNPs associated with %fPSA less than 5 x 10<sup>-8</sup> are centralized in a 22-kb region between two recombination hotspots. This region contains the entire <em>KLKP1</em> gene and a majority of the <em>KLK2</em> gene, except exon 1 and intron 1. This locus is distinct from the region containing <em>KLK3</em> (the gene encoding PSA) and the tPSA-associated locus at 19q13 (rs17632542) [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_321246782" role="button" aria-expanded="false" aria-haspopup="true">17</a>]. As shown in Table W4, all of the SNPs at 19q13 with <em>P</em> &lt; 10<sup>-5</sup> for %fPSA were in LD with rs1354774, with <em>r</em><sup>2</sup> values ranging from 0.519 to 1. None of the associations for these SNPs reached a significance level of 0.01 after conditioning on rs1354774.</p><p id="__p22">To evaluate whether the %fPSA-associated loci at 12p13 and 19q13 were also associated with tPSA (<a href="/pmc/articles/PMC3556942/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>), we tested the associations of rs3213764 and rs1354774 with levels of tPSA. The SNP rs3213764 at 12p13 was suggestively associated with tPSA (<em>P</em><sub>combined</sub> = .015). However, no association was observed between rs1354774 at 19q13 and tPSA levels (<em>P</em><sub>combined</sub> = .904). We further evaluated whether these two loci were also associated with prostate cancer risk in case-control studies (REDUCE: 410 new cases and 1234 non-cases in a four-year follow-up of the placebo group; CAPS: 2899 cases and 1722 controls) or prostate cancer aggressiveness in case-only studies (REDUCE: 124 aggressive and 281 nonaggressive cases; CAPS: 1231 aggressive and 1619 nonaggressive cases). As shown in <a href="/pmc/articles/PMC3556942/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>, no associations were observed for prostate cancer risk (<em>P</em><sub>combined</sub> = .214 and .722, respectively) or aggressiveness (<em>P</em><sub>combined</sub> = .737 and .716, respectively).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p39">Relationships of the Loci <em>ATF7IP</em> at 12p13 and <em>KLK2</em> at 19q13 with tPSA Levels.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139771008184256" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><td rowspan="1" colspan="1">Locus</td><td rowspan="1" colspan="1">SNP (Minor Allele)</td><td colspan="3" rowspan="1" align="left">REDUCE (<em>N</em> = 3192)</td><td colspan="3" rowspan="1" align="left">CAPS (<em>N</em> = 464)</td><td rowspan="1" colspan="1"><em>P</em><sub>combined</sub><sup>*</sup></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td colspan="3" rowspan="1"><hr></td><td colspan="3" rowspan="1"><hr></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Mean<sup>†</sup></td><td rowspan="1" colspan="1"><em>β</em></td><td rowspan="1" colspan="1"><em>P</em><sup>‡</sup></td><td rowspan="1" colspan="1">Mean<sup>†</sup></td><td rowspan="1" colspan="1"><em>β</em></td><td rowspan="1" colspan="1"><em>P</em><sup>‡</sup></td><td rowspan="1" colspan="1"></td></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">12p13 (<em>ATF7IP</em>)</td><td rowspan="1" colspan="1">rs3213764 (G)</td><td rowspan="1" colspan="1">6.00/5.86/5.81</td><td rowspan="1" colspan="1">-0.015</td><td rowspan="1" colspan="1">0.069</td><td rowspan="1" colspan="1">4.88/4.41/4.37</td><td rowspan="1" colspan="1">-0.053</td><td rowspan="1" colspan="1">0.027</td><td rowspan="1" colspan="1">0.015</td></tr><tr><td rowspan="1" colspan="1">19q13 (<em>KLK2</em>)</td><td rowspan="1" colspan="1">rs1354774 (G)</td><td rowspan="1" colspan="1">5.89/5.85/6.00</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1">0.846</td><td rowspan="1" colspan="1">4.58/4.49/4.31</td><td rowspan="1" colspan="1">-0.024</td><td rowspan="1" colspan="1">0.342</td><td rowspan="1" colspan="1">0.904</td></tr></tbody></table></div><div id="largeobj_idm139771008184256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3556942/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF5"><sup>*</sup><em>P</em>combined values were estimated using inverse variance-weighted meta-analyses according to regression coefficients (<em>β</em>) and corresponding SEs across studies.</div><div id="TF6"><sup>†</sup>Mean values of tPSA (%) by genotypes (major homozygote/heterozygote/minor homozygote).</div><div id="TF7"><sup>‡</sup><em>P</em> values were from linear regression models adjusted for age.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p43">Relationships of the Loci <em>ATF7IP</em> at 12p13 and <em>KLK2</em> at 19q13 with Prostate Cancer Risk (Case-Control Study) or Aggressiveness (Case-Only Study).</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139771016041568" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="top"><tr><td rowspan="1" colspan="1">Locus</td><td rowspan="1" colspan="1">SNP (Minor Allele)</td><td colspan="4" rowspan="1" align="left">Case-Control Study</td><td colspan="4" rowspan="1" align="left">Case-Only Study</td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td colspan="4" rowspan="1"><hr></td><td colspan="4" rowspan="1"><hr></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">MAF<sub>case/control</sub></td><td rowspan="1" colspan="1">OR (95% CI)<sup>*</sup></td><td rowspan="1" colspan="1"><em>P</em><sup>*</sup></td><td rowspan="1" colspan="1">MAF<sub>agg/nonagg</sub></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">OR (95% CI)<sup>*</sup></td><td rowspan="1" colspan="1"><em>P</em><sup>*</sup></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td colspan="2" rowspan="1"><hr></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td colspan="2" rowspan="1"><hr></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">REDUCE (<em>N</em> = 410/1234)</td><td rowspan="1" colspan="1">CAPS (<em>N</em> = 2899/1722)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">REDUCE (<em>N</em> = 124/281)</td><td rowspan="1" colspan="1">CAPS (<em>N</em> = 1231/1619)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></thead><tbody><tr><td rowspan="1" colspan="1"><em>ATF7IP</em></td><td rowspan="1" colspan="1">rs3213764 (G)</td><td rowspan="1" colspan="1">0.445/0.465</td><td rowspan="1" colspan="1">0.519/0.499</td><td rowspan="1" colspan="1">1.05 (0.97–1.13)</td><td rowspan="1" colspan="1">0.214</td><td rowspan="1" colspan="1">0.456/0.441</td><td rowspan="1" colspan="1">0.524/0.517</td><td rowspan="1" colspan="1">1.02 (0.92.1.13)</td><td rowspan="1" colspan="1">0.737</td></tr><tr><td rowspan="1" colspan="1"><em>KLK2</em></td><td rowspan="1" colspan="1">rs1354774 (G)</td><td rowspan="1" colspan="1">0.345/0.341</td><td rowspan="1" colspan="1">0.340/0.335</td><td rowspan="1" colspan="1">1.01 (0.94–1.10)</td><td rowspan="1" colspan="1">0.722</td><td rowspan="1" colspan="1">0.367/0.336</td><td rowspan="1" colspan="1">0.332/0.344</td><td rowspan="1" colspan="1">0.98 (0.88.1.09)</td><td rowspan="1" colspan="1">0.716</td></tr></tbody></table></div><div id="largeobj_idm139771016041568" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3556942/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TF8"><sup>*</sup>Odds ratios (ORs), 95% confidence intervals (CIs), and <em>P</em> values were estimated using inverse variance-weighted meta-analyses according to regression coefficients and corresponding SEs across REDUCE and CAPS studies.</div></div></div><p id="__p23" class="p p-last">We further calculated personalized %fPSA cutoff values to interpret the effects of the two identified variants on the variation of % fPSA levels. We adopted the methods reported by Gudmundsson et al. [<a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_321246783" role="button" aria-expanded="false" aria-haspopup="true">17</a>] and calculated a personalized%fPSA cutoff value corresponding to the commonly used cutoff of 25%. As shown in <a href="#SD1" rid="SD1" class=" supplementary-material">Figure W2</a>, in contrast to the uniform %fPSA cutoff value of 25%, a personalized cutoff may range from 21.3% to 27.9% for an individual after genetic correction.</p></div><div id="__sec13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec13title">Discussion</h2><p id="__p24" class="p p-first">PSA circulates within the serum in unbound (free) form or bound to one of several antiproteases, most predominantly α-1-antichymotrypsin (ACT/SERPINA3) [<a href="#R18" rid="R18 R19" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">18,19</a>]. fPSA represents 10% to 40% of tPSA. Previous studies suggest that %fPSA predicts risk of prostate cancer independent of tPSA and contributes modest diagnostic enhancements above and beyond tPSA alone amongmen in the “diagnostic gray zone” [<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751153" role="button" aria-expanded="false" aria-haspopup="true">9</a>]. Numerous studies have explored methods of optimizing the diagnostic accuracy of %fPSA [<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751146" role="button" aria-expanded="false" aria-haspopup="true">10</a>]. In the current study, we focused on the influence of genetic factors on %fPSA using a GWAS approach, leading to the identification of two loci at 12p13 and 19q13 that are associated with %fPSA, especially among men with intermediate tPSA levels. These findings may be useful for improving the performance of %fPSA in distinguishing malignant from benign prostate disease. The possible added value of incorporating these SNPs within existing PSA screening practices needs to be evaluated in future studies, as this may help avoid significant numbers of unnecessary and invasive biopsies.</p><p id="__p25">Our results indicate that an SNP 1354774 at 19q13 is associated with %fPSA but not with tPSA. This SNP is located in the 3′-flanking region of <em>KLK2</em> and an intron of <em>KLKP1</em>. As separated by a recombination hotspot (<a href="/pmc/articles/PMC3556942/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>), our lead SNP (rs1354774) is independent of SNPs in the <em>KLK3</em> locus at 19q13 previously reported to be associated with tPSA and prostate cancer risk [<a href="#R17" rid="R17 R20" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">17,20</a>]. Specifically, rs1354774 is not in LD with either rs17632542 (<em>r</em><sup>2</sup> = 0.000 and 0.049 for REDUCE GWAS and 1000 Genomes, respectively) or rs2735839 (<em>r</em><sup>2</sup> = 0.001 and 0.002 for REDUCE GWAS and 1000 Genomes, respectively). In contrast to the complex associations observed between rs1763542 (or rs2735839) and tPSA and prostate cancer risk, rs1354774 was not associated with prostate cancer risk and aggressiveness. Interestingly, Nam et al. [<a href="#R21" rid="R21 R22" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">21,22</a>] and our group [<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751150" role="button" aria-expanded="false" aria-haspopup="true">23</a>] have shown that this locus (defined by rs198977) was also associated with blood KLK2 levels. The SNP rs198977, showing moderate LD with rs1354774 (<em>r</em><sup>2</sup> = 0.505 and 0.547 for REDUCE GWAS and 1000 Genomes, respectively), was also associated with %fPSA (<em>P</em> = 4.77 x 10<sup>-8</sup> in REDUCE) and fPSA (<em>P</em> = 6.55 x 10<sup>-7</sup> in REDUCE) in this study. Because multiple SNPs in LD with rs135774 at 19q13 were associated with %fPSA and fPSA, we cannot dissect whether any of these variants are independently functional and how these variants at 19q13 might affect individual % fPSA and fPSA values at this stage. The <em>KLK2</em> gene product has been shown to convert the inactive PSA zymogen to catalytically active PSA, which may influence the ratio (%fPSA) in the blood, and act as a physiologic PSA processing protease in the conversion of pro-PSA into active PSA [<a href="#R24" rid="R24 R25 R26" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">24–26</a>]. %fPSA was decreased when KLK3 and KLK2-expressing cells were co-inoculated subcutaneously and double transgenic mice expressing both <em>KLK2</em> and <em>KLK3</em> in the prostate produced more active PSA compared to single transgenic animals [<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751137" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. Taken together, these multiple lines of evidence suggest that genetic variants in 19q13 may modify fPSA and%fPSA by influencing the biologic function of the <em>KLK2</em> gene product.</p><p id="__p26">We also identified a locus at 12p13 that was associated with %fPSA at a genome-wide significance level. The most significant SNP, rs3213764, results in an amino acid substitution (K530R) in <em>ATF7IP</em>, which encodes for the activating transcription factor 7 interacting protein [also known as MBD1-containing chromatin-associated factor 1 (<em>MCAF1</em>)]. Of interest, <em>ATF7IP</em> has been identified as a susceptibility gene for testicular germ cell tumor (TGCT) in a recent GWAS [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_353259196" role="button" aria-expanded="false" aria-haspopup="true">28</a>]. The reported SNP rs2900333 in TGCT GWAS is in moderate LD with missense variant rs3213764 (<em>r</em><sup>2</sup> = 0.534 and 0.553 for REDUCE GWAS and 1000 Genomes, respectively). The TGCT-related SNP rs2900333 was also associated with %fPSA in our REDUCE GWAS (<em>P</em> = 6.56 x 10<sup>-8</sup>). These results suggest that %fPSA shares the same genetic locus in <em>ATF7IP</em> as that for TGCT susceptibility. <em>ATF7IP</em> was found to regulate telomerase activity by acting on the promoter of <em>TERT</em> and <em>TERC</em> in an Sp1-dependent manner [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751140" role="button" aria-expanded="false" aria-haspopup="true">29</a>]. Overexpression of <em>ATF7IP</em> was also frequently observed in cancers [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751147" role="button" aria-expanded="false" aria-haspopup="true">29</a>]. The locus at <em>TERT</em> on 5p15 (defined by rs2736098) regulates telomerase activity and has been associated with tPSA and risk of multiple cancers, including prostate cancer [<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_500614805" role="button" aria-expanded="false" aria-haspopup="true">30</a>] and TGCT [<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_353259195" role="button" aria-expanded="false" aria-haspopup="true">28</a>]. In addition, we observed a suggestive association of rs3213764 in <em>ATF7IP</em> with circulating levels of tPSA (<em>P</em> = .015) but not with prostate cancer risk (<em>P</em> = .214) or aggressiveness (<em>P</em> = .737). However, these results were primarily because of the limited sample size, and further studies with larger sample sizes are needed to further clarify the relationships. Nevertheless, the exact mechanism by which genetic variants in <em>ATF7IP</em> may have an effect on PSA regulation is not known. It is possible that <em>ATF7IP</em> may regulate key genes in PSA processing as it does in <em>TERT</em> [<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_295751134" role="button" aria-expanded="false" aria-haspopup="true">29</a>] and thus mediates the overall proportion of fPSA in circulation.</p><p id="__p27" class="p p-last">The relatively small sample size in the replication set is a limitation of this study, especially in the analyses restricted to individuals with a tPSA level range of 2.5 to 10 ng/ml. This may have resulted in false-negative findings because of limited statistical power. The moderate sample size also did not provide sufficient power to more extensively replicate additional suggestive signals (e.g., P values ranging from 10<sup>-3</sup> to 10<sup>-5</sup>) observed in the REDUCE GWAS. In addition, the different levels of %fPSA between REDUCE and CAPS may also result in falsenegative results. However, this is not a major concern since we successfully replicated our findings in the CAPS population. Nevertheless, the two identified variants could explain only 2% of variance of %fPSA, which may lead to limited clinical utility. The identification of additional genetic loci that contribute to the level of %fPSA is needed in order to define a more differentiated personal cutoff value. The clinical value of personalized PSA test also needs to be evaluated in other independent and large prospective studies.</p></div><div id="__sec14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec14title">Conclusions</h2><p id="__p28" class="p p-first-last">Two loci at 12p13 (rs3213764 in <em>ATF7IP</em>) and 19q13 (rs1354774 near <em>KLK2</em>) are identified to be associated with %fPSA. These findings may provide insight into individual variance of %fPSA and may be clinically useful for improving the predictive accuracy of %fPSA in PSA screening.</p></div><div id="__sec15" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec15title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><!--caption a9--><strong>Supplementary Figures and Tables:</strong><div class="sup-box half_rhythm" id="d34e868"><a href="/pmc/articles/PMC3556942/bin/neo1501_0095SD1.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(148K, pdf)</sup></div></div></div><div id="idm139771016378944" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139771016378944title">Acknowledgments</h2><div class="sec"><p id="__p29">We thank the patients enrolled in REDUCE who provided consent and genetic samples that enabled this study and the clinicians who contributed their expertise in recruiting study patients for the REDUCE clinical study. Dave Pulford, Jennifer Aponte, Jon Charnecki, and Mary Ellyn Volk participated in consent reconciliation and sample management to enable genetic sample selection for inclusion and genotype determination. Karen King provided data management support for this project. We appreciate the assistance of Lauren Marmor in coordinating the support of the Avodart Collaborative Research Team. Editorial assistance was provided by Aubrey Turner.</p></div></div><div id="idm139771016377392" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139771016377392title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><sup>1</sup>This study was supported in part by a National Cancer Institute RC2 grant (CA148463) to J. Xu, a research contract by GlaxoSmithKline (GSK) to J. Xu, National Cancer Institute (grants R33 CA 127768-02 and P50-CA92629), Swedish Cancer Society (3455), Swedish Research Council (Medicine) (20095), the Sidney Kimmel Center for Prostate and Urologic Cancers, and David H. Koch through the Prostate Cancer Foundation to H. Lilja. J. Xu and J. Sun certify that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: H. Lilja holds patents for free PSA, intact PSA, and hK2 assays. L. D. Condreay was a GSK employee during this study and holds stock in GSK.</p><p class="fn sec" id="FN2"><sup>2</sup>This article refers to supplementary materials, which are designated by <a href="#SD1" rid="SD1" class=" supplementary-material">Tables W1</a> to <a href="#SD1" rid="SD1" class=" supplementary-material">W4</a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Figures W1</a> and <a href="#SD1" rid="SD1" class=" supplementary-material">W2</a> and are available online at www.neoplasia.com.</p></div></div><div id="idm139771019807584" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139771019807584title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, et al.  Prostate-cancer mortality at 11 years of follow-up. <span><span class="ref-journal">N Engl J Med. </span>2012;<span class="ref-vol">366</span>:981–990.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6027585/">PMC free article</a>]</span> [<a href="/pubmed/22417251" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Prostate-cancer+mortality+at+11+years+of+follow-up&amp;author=FH+Schroder&amp;author=J+Hugosson&amp;author=MJ+Roobol&amp;author=TL+Tammela&amp;author=S+Ciatto&amp;volume=366&amp;publication_year=2012&amp;pages=981-990&amp;pmid=22417251&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">Oncol 11</span>:725–732.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4089887/">PMC free article</a>]</span> [<a href="/pubmed/20598634" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Mortality+results+from+the+Göteborg+randomised+population-based+prostate-cancer+screening+trial&amp;author=J+Hugosson&amp;author=S+Carlsson&amp;author=G+Aus&amp;author=S+Bergdahl&amp;author=A+Khatami&amp;volume=Oncol+11&amp;publication_year=2010&amp;pages=725-732&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Andriole GL, Crawford ED, Grubb RL, III, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, et al.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. <span><span class="ref-journal">J Natl Cancer Inst. </span>2012;<span class="ref-vol">104</span>:125–132.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3260132/">PMC free article</a>]</span> [<a href="/pubmed/22228146" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Prostate+cancer+screening+in+the+randomized+Prostate,+Lung,+Colorectal,+and+Ovarian+Cancer+Screening+Trial:+mortality+results+after+13+years+of+follow-up&amp;author=GL+Andriole&amp;author=ED+Crawford&amp;author=RL+Grubb&amp;author=SS+Buys&amp;author=D+Chia&amp;volume=104&amp;publication_year=2012&amp;pages=125-132&amp;pmid=22228146&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. <span><span class="ref-journal">J Natl Cancer Inst. </span>2009;<span class="ref-vol">101</span>:374–383.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2720697/">PMC free article</a>]</span> [<a href="/pubmed/19276453" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Lead+time+and+overdiagnosis+in+prostate-specific+antigen+screening:+importance+of+methods+and+context&amp;author=G+Draisma&amp;author=R+Etzioni&amp;author=A+Tsodikov&amp;author=A+Mariotto&amp;author=E+Wever&amp;volume=101&amp;publication_year=2009&amp;pages=374-383&amp;pmid=19276453&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. <span><span class="ref-journal">Ann Intern Med. </span>2008;<span class="ref-vol">148</span>:435–448.</span> [<a href="/pubmed/18252677" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=Systematic+review:+comparative+effectiveness+and+harms+of+treatments+for+clinically+localized+prostate+cancer&amp;author=TJ+Wilt&amp;author=R+MacDonald&amp;author=I+Rutks&amp;author=TA+Shamliyan&amp;author=BC+Taylor&amp;volume=148&amp;publication_year=2008&amp;pages=435-448&amp;pmid=18252677&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Vickers AJ, Cronin AM, Bjork T, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Ulmert D, Lilja H. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. <span><span class="ref-journal">BMJ. </span>2010;<span class="ref-vol">341</span>:c4521.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2939950/">PMC free article</a>]</span> [<a href="/pubmed/20843935" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Prostate+specific+antigen+concentration+at+age+60+and+death+or+metastasis+from+prostate+cancer:+case-control+study&amp;author=AJ+Vickers&amp;author=AM+Cronin&amp;author=T+Bjork&amp;author=J+Manjer&amp;author=PM+Nilsson&amp;volume=341&amp;publication_year=2010&amp;pages=c4521&amp;pmid=20843935&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA., Jr Operating characteristics of prostatespecific antigen in men with an initial PSA level of 3.0 ng/ml or lower. <span><span class="ref-journal">JAMA. </span>2005;<span class="ref-vol">294</span>:66–70.</span> [<a href="/pubmed/15998892" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Operating+characteristics+of+prostatespecific+antigen+in+men+with+an+initial+PSA+level+of+3.0+ng/ml+or+lower&amp;author=IM+Thompson&amp;author=DP+Ankerst&amp;author=C+Chi&amp;author=MS+Lucia&amp;author=PJ+Goodman&amp;volume=294&amp;publication_year=2005&amp;pages=66-70&amp;pmid=15998892&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, et al.  Prostate specific antigen best practice statement: 2009 update. <span><span class="ref-journal">J Urol. </span>2009;<span class="ref-vol">182</span>:2232–2241.</span> [<a href="/pubmed/19781717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=Prostate+specific+antigen+best+practice+statement:+2009+update&amp;author=KL+Greene&amp;author=PC+Albertsen&amp;author=RJ+Babaian&amp;author=HB+Carter&amp;author=PH+Gann&amp;volume=182&amp;publication_year=2009&amp;pages=2232-2241&amp;pmid=19781717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis. <span><span class="ref-journal">Eur Urol. </span>2005;<span class="ref-vol">48</span>:386–399.</span> discussion 398–389. [<a href="/pubmed/15982797" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Urol&amp;title=Use+of+prostate-specific+antigen+(PSA)+isoforms+for+the+detection+of+prostate+cancer+in+men+with+a+PSA+level+of+2–10+ng/ml:+systematic+review+and+meta-analysis&amp;author=AW+Roddam&amp;author=MJ+Duffy&amp;author=FC+Hamdy&amp;author=AM+Ward&amp;author=J+Patnick&amp;volume=48&amp;publication_year=2005&amp;pages=386-399&amp;pmid=15982797&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2000;<span class="ref-vol">9</span>:1133–1147.</span> [<a href="/pubmed/11097220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Molecular+forms+of+prostate-specific+antigen+and+human+kallikrein+2+as+promising+tools+for+early+diagnosis+of+prostate+cancer&amp;author=C+Stephan&amp;author=K+Jung&amp;author=M+Lein&amp;author=P+Sinha&amp;author=D+Schnorr&amp;volume=9&amp;publication_year=2000&amp;pages=1133-1147&amp;pmid=11097220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. <span><span class="ref-journal">J Urol. </span>2004;<span class="ref-vol">172</span>:1314–1317.</span> [<a href="/pubmed/15371831" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Urol&amp;title=Chemoprevention+of+prostate+cancer+in+men+at+high+risk:+rationale+and+design+of+the+reduction+by+dutasteride+of+prostate+cancer+events+(REDUCE)+trial&amp;author=G+Andriole&amp;author=D+Bostwick&amp;author=O+Brawley&amp;author=L+Gomella&amp;author=M+Marberger&amp;volume=172&amp;publication_year=2004&amp;pages=1314-1317&amp;pmid=15371831&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, et al.  Effect of dutasteride on the risk of prostate cancer. <span><span class="ref-journal">N Engl J Med. </span>2010;<span class="ref-vol">362</span>:1192–1202.</span> [<a href="/pubmed/20357281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Effect+of+dutasteride+on+the+risk+of+prostate+cancer&amp;author=GL+Andriole&amp;author=DG+Bostwick&amp;author=OW+Brawley&amp;author=LG+Gomella&amp;author=M+Marberger&amp;volume=362&amp;publication_year=2010&amp;pages=1192-1202&amp;pmid=20357281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, et al.  Cumulative association of five genetic variants with prostate cancer. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">358</span>:910–919.</span> [<a href="/pubmed/18199855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Cumulative+association+of+five+genetic+variants+with+prostate+cancer&amp;author=SL+Zheng&amp;author=J+Sun&amp;author=F+Wiklund&amp;author=S+Smith&amp;author=P+Stattin&amp;volume=358&amp;publication_year=2008&amp;pages=910-919&amp;pmid=18199855&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Mitrunen K, Pettersson K, Piironen T, Bjork T, Lilja H, Lovgren T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. <span><span class="ref-journal">Clin Chem. </span>1995;<span class="ref-vol">41</span>:1115–1120.</span> [<a href="/pubmed/7543033" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Dual-label+one-step+immunoassay+for+simultaneous+measurement+of+free+and+total+prostate-specific+antigen+concentrations+and+ratios+in+serum&amp;author=K+Mitrunen&amp;author=K+Pettersson&amp;author=T+Piironen&amp;author=T+Bjork&amp;author=H+Lilja&amp;volume=41&amp;publication_year=1995&amp;pages=1115-1120&amp;pmid=7543033&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:906–913.</span> [<a href="/pubmed/17572673" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+new+multipoint+method+for+genome-wide+association+studies+by+imputation+of+genotypes&amp;author=J+Marchini&amp;author=B+Howie&amp;author=S+Myers&amp;author=G+McVean&amp;author=P+Donnelly&amp;volume=39&amp;publication_year=2007&amp;pages=906-913&amp;pmid=17572673&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Principal+components+analysis+corrects+for+stratification+in+genome-wide+association+studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, et al.  Genetic correction of PSA values using sequence variants associated with PSA levels. <span><span class="ref-journal">Sci Transl Med. </span>2010;<span class="ref-vol">2</span>:62ra92.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3564581/">PMC free article</a>]</span> [<a href="/pubmed/21160077" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Transl+Med&amp;title=Genetic+correction+of+PSA+values+using+sequence+variants+associated+with+PSA+levels&amp;author=J+Gudmundsson&amp;author=S+Besenbacher&amp;author=P+Sulem&amp;author=DF+Gudbjartsson&amp;author=I+Olafsson&amp;volume=2&amp;publication_year=2010&amp;pages=62ra92&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostatespecific antigen and its reactions with extracellular serine proteinase inhibitors. <span><span class="ref-journal">Eur J Biochem. </span>1990;<span class="ref-vol">194</span>:755–763.</span> [<a href="/pubmed/1702714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Biochem&amp;title=Enzymatic+activity+of+prostatespecific+antigen+and+its+reactions+with+extracellular+serine+proteinase+inhibitors&amp;author=A+Christensson&amp;author=CB+Laurell&amp;author=H+Lilja&amp;volume=194&amp;publication_year=1990&amp;pages=755-763&amp;pmid=1702714&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. <span><span class="ref-journal">Clin Chem. </span>1991;<span class="ref-vol">37</span>:1618–1625.</span> [<a href="/pubmed/1716536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Prostate-specific+antigen+in+serum+occurs+predominantly+in+complex+with+alpha+1-antichymotrypsin&amp;author=H+Lilja&amp;author=A+Christensson&amp;author=U+Dahlen&amp;author=MT+Matikainen&amp;author=O+Nilsson&amp;volume=37&amp;publication_year=1991&amp;pages=1618-1625&amp;pmid=1716536&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, et al.  Multiple newly identified loci associated with prostate cancer susceptibility. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:316–321.</span> [<a href="/pubmed/18264097" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Multiple+newly+identified+loci+associated+with+prostate+cancer+susceptibility&amp;author=RA+Eeles&amp;author=Z+Kote-Jarai&amp;author=GG+Giles&amp;author=AA+Olama&amp;author=M+Guy&amp;volume=40&amp;publication_year=2008&amp;pages=316-321&amp;pmid=18264097&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Nam RK, Zhang WW, Klotz LH, Trachtenberg J, Jewett MA, Sweet J, Toi A, Teahan S, Venkateswaran V, Sugar L, et al.  Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. <span><span class="ref-journal">Clin Cancer Res. </span>2006;<span class="ref-vol">12</span>:6452–6458.</span> [<a href="/pubmed/17085659" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Variants+of+the+hK2+protein+gene+(KLK2)+are+associated+with+serum+hK2+levels+and+predict+the+presence+of+prostate+cancer+at+biopsy&amp;author=RK+Nam&amp;author=WW+Zhang&amp;author=LH+Klotz&amp;author=J+Trachtenberg&amp;author=MA+Jewett&amp;volume=12&amp;publication_year=2006&amp;pages=6452-6458&amp;pmid=17085659&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Nam RK, Zhang WW, Trachtenberg J, Diamandis E, Toi A, Emami M, Ho M, Sweet J, Evans A, Jewett MA, et al.  Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. <span><span class="ref-journal">J Clin Oncol. </span>2003;<span class="ref-vol">21</span>:2312–2319.</span> [<a href="/pubmed/12805332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Single+nucleotide+polymorphism+of+the+human+kallikrein-2+gene+highly+correlates+with+serum+human+kallikrein-2+levels+and+in+combination+enhances+prostate+cancer+detection&amp;author=RK+Nam&amp;author=WW+Zhang&amp;author=J+Trachtenberg&amp;author=E+Diamandis&amp;author=A+Toi&amp;volume=21&amp;publication_year=2003&amp;pages=2312-2319&amp;pmid=12805332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, et al.  Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. <span><span class="ref-journal">Cancer Prev Res (Phila) </span>2010;<span class="ref-vol">3</span>:611–619.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2865570/">PMC free article</a>]</span> [<a href="/pubmed/20424135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Prev+Res+(Phila)&amp;title=Blood+biomarker+levels+to+aid+discovery+of+cancer-related+single-nucleotide+polymorphisms:+kallikreins+and+prostate+cancer&amp;author=RJ+Klein&amp;author=C+Hallden&amp;author=AM+Cronin&amp;author=A+Ploner&amp;author=F+Wiklund&amp;volume=3&amp;publication_year=2010&amp;pages=611-619&amp;pmid=20424135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. <span><span class="ref-journal">Cancer Res. </span>1997;<span class="ref-vol">57</span>:3111–3114.</span> [<a href="/pubmed/9242434" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Expression+of+pro+form+of+prostate-specific+antigen+by+mammalian+cells+and+its+conversion+to+mature,+active+form+by+human+kallikrein+2&amp;author=A+Kumar&amp;author=SD+Mikolajczyk&amp;author=AS+Goel&amp;author=LS+Millar&amp;author=MS+Saedi&amp;volume=57&amp;publication_year=1997&amp;pages=3111-3114&amp;pmid=9242434&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Lovgren J, Rajakoski K, Karp M, Lundwall A, Lilja H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1997;<span class="ref-vol">238</span>:549–555.</span> [<a href="/pubmed/9299549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Activation+of+the+zymogen+form+of+prostate-specific+antigen+by+human+glandular+kallikrein+2&amp;author=J+Lovgren&amp;author=K+Rajakoski&amp;author=M+Karp&amp;author=A+Lundwall&amp;author=H+Lilja&amp;volume=238&amp;publication_year=1997&amp;pages=549-555&amp;pmid=9299549&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Takayama TK, Fujikawa K, Davie EW. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. <span><span class="ref-journal">J Biol Chem. </span>1997;<span class="ref-vol">272</span>:21582–21588.</span> [<a href="/pubmed/9261179" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Characterization+of+the+precursor+of+prostate-specific+antigen.+Activation+by+trypsin+and+by+human+glandular+kallikrein&amp;author=TK+Takayama&amp;author=K+Fujikawa&amp;author=EW+Davie&amp;volume=272&amp;publication_year=1997&amp;pages=21582-21588&amp;pmid=9261179&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Williams SA, Xu Y, DeMarzo AM, Isaacs JT, Denmeade SR. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer <em>ex vivo</em> models and in prostate-targeted PSA/KLK2 double transgenic mice. <span><span class="ref-journal">Prostate. </span>2010;<span class="ref-vol">70</span>:788–796.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3454520/">PMC free article</a>]</span> [<a href="/pubmed/20058238" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostate&amp;title=Prostate-specific+antigen+(PSA)+is+activated+by+KLK2+in+prostate+cancer+ex+vivo+models+and+in+prostate-targeted+PSA/KLK2+double+transgenic+mice&amp;author=SA+Williams&amp;author=Y+Xu&amp;author=AM+DeMarzo&amp;author=JT+Isaacs&amp;author=SR+Denmeade&amp;volume=70&amp;publication_year=2010&amp;pages=788-796&amp;pmid=20058238&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, et al.  Variants near DMRT1, TERT and <em>ATF7IP</em> are associated with testicular germ cell cancer. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:604–607.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3773909/">PMC free article</a>]</span> [<a href="/pubmed/20543847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Variants+near+DMRT1,+TERT+and+ATF7IP+are+associated+with+testicular+germ+cell+cancer&amp;author=C+Turnbull&amp;author=EA+Rapley&amp;author=S+Seal&amp;author=D+Pernet&amp;author=A+Renwick&amp;volume=42&amp;publication_year=2010&amp;pages=604-607&amp;pmid=20543847&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Liu L, Ishihara K, Ichimura T, Fujita N, Hino S, Tomita S, Watanabe S, Saitoh N, Ito T, Nakao M. MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:5165–5174.</span> [<a href="/pubmed/19106100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=MCAF1/AM+is+involved+in+Sp1-mediated+maintenance+of+cancer-associated+telomerase+activity&amp;author=L+Liu&amp;author=K+Ishihara&amp;author=T+Ichimura&amp;author=N+Fujita&amp;author=S+Hino&amp;volume=284&amp;publication_year=2009&amp;pages=5165-5174&amp;pmid=19106100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:221–227.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4525478/">PMC free article</a>]</span> [<a href="/pubmed/19151717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Sequence+variants+at+the+TERT-CLPTM1L+locus+associate+with+many+cancer+types&amp;author=T+Rafnar&amp;author=P+Sulem&amp;author=SN+Stacey&amp;author=F+Geller&amp;author=J+Gudmundsson&amp;volume=41&amp;publication_year=2009&amp;pages=221-227&amp;pmid=19151717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139771022208688title">Abstract</a></li><li><a href="#__sec5title">Introduction</a></li><li><a href="#__sec6title">Materials and Methods</a></li><li><a href="#__sec12title">Results</a></li><li><a href="#__sec13title">Discussion</a></li><li><a href="#__sec14title">Conclusions</a></li><li><a href="#__sec15title">Supplementary Material</a></li><li><a href="#idm139771016378944title">Acknowledgments</a></li><li><a href="#idm139771016377392title">Footnotes</a></li><li><a href="#idm139771019807584title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Neoplasia (New York, N.Y.)</span> are provided here courtesy of <strong>Neoplasia Press</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3556942/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3556942/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3556942/pdf/neo1501_0095.pdf">PDF (717K)</a></li> | <li><a href="#" data-citationid="PMC3556942" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556942%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556942%2F&amp;text=Genome-wide%20Association%20Study%20Identifies%20Loci%20at%20ATF7IP%20and%20KLK2%20Associated%20with%20Percentage%20of%20Circulating%20Free%20PSA%0A" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556942%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23359319" data-aiid="3556942" data-aid="3556942" data-iid="218853" data-domainid="367" data-domain="neoplasia" data-accid="PMC3556942" data-md5="d30cbfc2587cff58daefcc85bd3994ee">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="3556942" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/14501718" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.</a><span class="source">[J Urol. 2003]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Becker C, Piironen T, Pettersson K, Hugosson J, Lilja H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Urol. 2003 Oct; 170(4 Pt 1):1169-74. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25443923" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less.</a><span class="source">[Urology. 2014]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sasaki M, Ishidoya S, Ito A, Saito H, Yamada S, Mitsuzuka K, Kaiho Y, Shibuya D, Yamaguchi T, Arai Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Urology. 2014 Nov; 84(5):1163-7. Epub 2014 Oct 24.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/24270797" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.</a><span class="source">[Clin Chem. 2014]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sävblom C, Halldén C, Cronin AM, Säll T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Chem. 2014 Mar; 60(3):490-9. Epub 2013 Nov 22.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/16152616" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.</a><span class="source">[Int J Cancer. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK, Kattan MW, Eastham JA, Scardino PT, Huland H, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Cancer. 2006 Mar 1; 118(5):1234-40. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/19058905" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.</a><span class="source">[Eur Urol. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jansen FH, Roobol M, Jenster G, Schröder FH, Bangma CH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur Urol. 2009 Mar; 55(3):563-74. Epub 2008 Nov 29.</em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23359319&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23359319&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC5290311/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer</a><span class="source">[Nature Communications. 2017]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melander O, Kvale MN, Kwok PY, Schaefer C, Risch N, Van Den Eeden SK, Witte JS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nature Communications. 2017 Jan 31; 8: 14248</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC4592274/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy</a><span class="source">[PLoS ONE. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gilbert R, Martin RM, Evans DM, Tilling K, Davey Smith G, Kemp JP, Lane JA, Hamdy FC, Neal DE, Donovan JL, Metcalfe C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS ONE. 2015 Oct 2; 10(10): e0136735</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC4586077/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Associations of Prostate Cancer Risk Variants with Disease Aggressiveness: Results of the NCI-SPORE Genetics Working Group Analysis of 18,343 Cases</a><span class="source">[Human genetics. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Helfand BT, Roehl KA, Cooper PR, McGuire B, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Berndt S, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff P, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan JM, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Human genetics. 2015 Feb 26; 134(4): 439-450</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC4281884/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A Genetic-Based Approach to Personalized Prostate Cancer Screening and Treatment</a><span class="source">[Current opinion in urology. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Helfand BT, Catalona WJ, Xu J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Current opinion in urology. 2015 Jan; 25(1): 53-58</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC3884532/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cancer Subclonal Genetic Architecture as a Key to Personalized Medicine</a><span class="source">[Neoplasia (New York, N.Y.). 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rehemtulla A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neoplasia (New York, N.Y.). 2013 Dec; 15(12): 1410-1420</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-18" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-18" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=3556942" ref="reftype=Gene&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene_nucleotide&amp;IdsFromResult=3556942" ref="reftype=Gene%20(nucleotide)&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene (nucleotide)</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene (nucleotide)<div class="brieflinkpopdesc">Records in Gene identified from shared sequence links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=3556942" ref="reftype=GEO%20Profiles&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=3556942" ref="reftype=HomoloGene&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|HomoloGene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HomoloGene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3556942" ref="reftype=MedGen&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=nuccore&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nuccore&amp;IdsFromResult=3556942" ref="reftype=Nucleotide&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Nucleotide&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Nucleotide</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Nucleotide<div class="brieflinkpopdesc">Published Nucleotide sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/23359319/" ref="reftype=PubMed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3556942" ref="reftype=Taxonomy&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-26" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd5587f39a66eb03d2307ac">Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with...</a><div class="ralinkpop offscreen_noflow">Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
<div class="brieflinkpopdesc">Neoplasia (New York, N.Y.). 2013 Jan; 15(1)95</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd5585b39a66eb03d1c4454">Childhood intelligence is heritable, highly polygenic and associated with FNBP1L</a><div class="ralinkpop offscreen_noflow">Childhood intelligence is heritable, highly polygenic and associated with FNBP1L<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2014 Feb; 19(2)253</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd5582ddd2142621d0236b8">Genetic Variants Associated with Breast Cancer Risk for Ashkenazi Jewish Women w...</a><div class="ralinkpop offscreen_noflow">Genetic Variants Associated with Breast Cancer Risk for Ashkenazi Jewish Women with Strong Family Histories but No Identifiable BRCA1/2 Mutation<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2013 May; 132(5)523</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd5580edde0893a8b27f6f4">Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteopor...</a><div class="ralinkpop offscreen_noflow">Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fracture<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2013 Apr; 50(4)212</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd557d575f66d018ffd7299">Genome-wide significant locus of beta-trace protein, a novel kidney function bio...</a><div class="ralinkpop offscreen_noflow">Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans<div class="brieflinkpopdesc">Nephrology Dialysis Transplantation. 2013 Jun; 28(6)1497</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="position: absolute; visibility: visible; width: 370px; top: 1306px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul><li class="two_line" reference_id="R3">
<a href="/pubmed/22228146/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.</a><span class="one_line_source">[J Natl Cancer Inst.  2012]</span><div class="alt-note">
<div class="authors">Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, PLCO Project Team.</div>
<div class="citation">J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p7" name="crb--__p7" rid="__p7" style="position: absolute; visibility: visible; width: 370px; top: 1494px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R6">
<a href="/pubmed/20843935/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.</a><span class="one_line_source">[BMJ.  2010]</span><div class="alt-note">
<div class="authors">Vickers AJ, Cronin AM, Björk T, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Ulmert D, Lilja H</div>
<div class="citation">BMJ. 2010 Sep 14; 341():c4521.</div>
</div>
</li>
<li class="two_line" reference_id="R7">
<a href="/pubmed/15998892/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.</a><span class="one_line_source">[JAMA.  2005]</span><div class="alt-note">
<div class="authors">Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr</div>
<div class="citation">JAMA. 2005 Jul 6; 294(1):66-70.</div>
</div>
</li>
<li class="two_line" reference_id="R8">
<a href="/pubmed/19781717/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prostate specific antigen best practice statement: 2009 update.</a><span class="one_line_source">[J Urol.  2009]</span><div class="alt-note">
<div class="authors">Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P</div>
<div class="citation">J Urol. 2009 Nov; 182(5):2232-41.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1725px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="R9">
<a href="/pubmed/15982797/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.</a><span class="one_line_source">[Eur Urol.  2005]</span><div class="alt-note">
<div class="authors">Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE, NHS Prostate Cancer Risk Management Programme.</div>
<div class="citation">Eur Urol. 2005 Sep; 48(3):386-99; discussion 398-9.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/11097220/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.</a><span class="one_line_source">[Cancer Epidemiol Biomarkers Prev.  2000]</span><div class="alt-note">
<div class="authors">Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA</div>
<div class="citation">Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1133-47.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p10" name="crb--__p10" rid="__p10" style="position: absolute; visibility: visible; width: 370px; top: 2336px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul><li class="two_line" reference_id="R13">
<a href="/pubmed/18199855/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cumulative association of five genetic variants with prostate cancer.</a><span class="one_line_source">[N Engl J Med.  2008]</span><div class="alt-note">
<div class="authors">Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H</div>
<div class="citation">N Engl J Med. 2008 Feb 28; 358(9):910-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 2750px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul><li class="two_line" reference_id="R14">
<a href="/pubmed/7543033/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum.</a><span class="one_line_source">[Clin Chem.  1995]</span><div class="alt-note">
<div class="authors">Mitrunen K, Pettersson K, Piironen T, Björk T, Lilja H, Lövgren T</div>
<div class="citation">Clin Chem. 1995 Aug; 41(8 Pt 1):1115-20.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p14" name="crb--__p14" rid="__p14" style="position: absolute; visibility: visible; width: 370px; top: 3143px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul><li class="two_line" reference_id="R15">
<a href="/pubmed/17572673/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A new multipoint method for genome-wide association studies by imputation of genotypes.</a><span class="one_line_source">[Nat Genet.  2007]</span><div class="alt-note">
<div class="authors">Marchini J, Howie B, Myers S, McVean G, Donnelly P</div>
<div class="citation">Nat Genet. 2007 Jul; 39(7):906-13.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="position: absolute; visibility: visible; width: 370px; top: 3490px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="two_line" reference_id="R16">
<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Principal components analysis corrects for stratification in genome-wide association studies.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div>
<div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 3721px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul><li class="two_line" reference_id="R17">
<a href="/pubmed/21160077/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic correction of PSA values using sequence variants associated with PSA levels.</a><span class="one_line_source">[Sci Transl Med.  2010]</span><div class="alt-note">
<div class="authors">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K</div>
<div class="citation">Sci Transl Med. 2010 Dec 15; 2(62):62ra92.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 6751px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul><li class="two_line" reference_id="R17">
<a href="/pubmed/21160077/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic correction of PSA values using sequence variants associated with PSA levels.</a><span class="one_line_source">[Sci Transl Med.  2010]</span><div class="alt-note">
<div class="authors">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K</div>
<div class="citation">Sci Transl Med. 2010 Dec 15; 2(62):62ra92.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 8322px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul><li class="two_line" reference_id="R17">
<a href="/pubmed/21160077/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic correction of PSA values using sequence variants associated with PSA levels.</a><span class="one_line_source">[Sci Transl Med.  2010]</span><div class="alt-note">
<div class="authors">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K</div>
<div class="citation">Sci Transl Med. 2010 Dec 15; 2(62):62ra92.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24" style="position: absolute; visibility: visible; width: 370px; top: 8484px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="R9">
<a href="/pubmed/15982797/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.</a><span class="one_line_source">[Eur Urol.  2005]</span><div class="alt-note">
<div class="authors">Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE, NHS Prostate Cancer Risk Management Programme.</div>
<div class="citation">Eur Urol. 2005 Sep; 48(3):386-99; discussion 398-9.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/11097220/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.</a><span class="one_line_source">[Cancer Epidemiol Biomarkers Prev.  2000]</span><div class="alt-note">
<div class="authors">Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA</div>
<div class="citation">Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1133-47.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25" style="position: absolute; visibility: visible; width: 370px; top: 8737px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="two_line" reference_id="R23">
<a href="/pubmed/20424135/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.</a><span class="one_line_source">[Cancer Prev Res (Phila).  2010]</span><div class="alt-note">
<div class="authors">Klein RJ, Halldén C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, Vickers AJ, Grönberg H, Lilja H</div>
<div class="citation">Cancer Prev Res (Phila). 2010 May; 3(5):611-9.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="/pubmed/20058238/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.</a><span class="one_line_source">[Prostate.  2010]</span><div class="alt-note">
<div class="authors">Williams SA, Xu Y, De Marzo AM, Isaacs JT, Denmeade SR</div>
<div class="citation">Prostate. 2010 May 15; 70(7):788-96.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 9213px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="R28">
<a href="/pubmed/20543847/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop DT, Easton DF, Stratton MR, Rahman N, UK Testicular Cancer Collaboration.</div>
<div class="citation">Nat Genet. 2010 Jul; 42(7):604-7.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="/pubmed/19106100/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity.</a><span class="one_line_source">[J Biol Chem.  2009]</span><div class="alt-note">
<div class="authors">Liu L, Ishihara K, Ichimura T, Fujita N, Hino S, Tomita S, Watanabe S, Saitoh N, Ito T, Nakao M</div>
<div class="citation">J Biol Chem. 2009 Feb 20; 284(8):5165-74.</div>
</div>
</li>
<li class="two_line" reference_id="R30">
<a href="/pubmed/19151717/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.</a><span class="one_line_source">[Nat Genet.  2009]</span><div class="alt-note">
<div class="authors">Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blöndal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Höiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K</div>
<div class="citation">Nat Genet. 2009 Feb; 41(2):221-7.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1 R2" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.<div class="authors">Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, PLCO Project Team.</div><div class="citation">J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.</div><p>[<a href="/pubmed/22228146/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R3">Ref list</a>]</p></div><div id="body-link-popper-R4 R5" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.<div class="authors">Vickers AJ, Cronin AM, Björk T, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Ulmert D, Lilja H</div><div class="citation">BMJ. 2010 Sep 14; 341():c4521.</div><p>[<a href="/pubmed/20843935/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R6">Ref list</a>]</p></div><div id="body-link-popper-R7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.<div class="authors">Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr</div><div class="citation">JAMA. 2005 Jul 6; 294(1):66-70.</div><p>[<a href="/pubmed/15998892/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R7">Ref list</a>]</p></div><div id="body-link-popper-R8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prostate specific antigen best practice statement: 2009 update.<div class="authors">Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P</div><div class="citation">J Urol. 2009 Nov; 182(5):2232-41.</div><p>[<a href="/pubmed/19781717/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R8">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.<div class="authors">Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE, NHS Prostate Cancer Risk Management Programme.</div><div class="citation">Eur Urol. 2005 Sep; 48(3):386-99; discussion 398-9.</div><p>[<a href="/pubmed/15982797/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R9">Ref list</a>]</p></div><div id="body-link-popper-R10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.<div class="authors">Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA</div><div class="citation">Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1133-47.</div><p>[<a href="/pubmed/11097220/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R10">Ref list</a>]</p></div><div id="body-link-popper-R11 R12" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cumulative association of five genetic variants with prostate cancer.<div class="authors">Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Bälter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H</div><div class="citation">N Engl J Med. 2008 Feb 28; 358(9):910-9.</div><p>[<a href="/pubmed/18199855/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R13">Ref list</a>]</p></div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum.<div class="authors">Mitrunen K, Pettersson K, Piironen T, Björk T, Lilja H, Lövgren T</div><div class="citation">Clin Chem. 1995 Aug; 41(8 Pt 1):1115-20.</div><p>[<a href="/pubmed/7543033/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R14">Ref list</a>]</p></div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A new multipoint method for genome-wide association studies by imputation of genotypes.<div class="authors">Marchini J, Howie B, Myers S, McVean G, Donnelly P</div><div class="citation">Nat Genet. 2007 Jul; 39(7):906-13.</div><p>[<a href="/pubmed/17572673/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Principal components analysis corrects for stratification in genome-wide association studies.<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div><div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div><p>[<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R16">Ref list</a>]</p></div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genetic correction of PSA values using sequence variants associated with PSA levels.<div class="authors">Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K</div><div class="citation">Sci Transl Med. 2010 Dec 15; 2(62):62ra92.</div><p>[<a href="/pubmed/21160077/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R17">Ref list</a>]</p></div><div id="body-link-popper-R18 R19" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R17 R20" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R21 R22" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.<div class="authors">Klein RJ, Halldén C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, Vickers AJ, Grönberg H, Lilja H</div><div class="citation">Cancer Prev Res (Phila). 2010 May; 3(5):611-9.</div><p>[<a href="/pubmed/20424135/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R23">Ref list</a>]</p></div><div id="body-link-popper-R24 R25 R26" class="body-link-popper" style="display: none"></div><div id="body-link-popper-R27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.<div class="authors">Williams SA, Xu Y, De Marzo AM, Isaacs JT, Denmeade SR</div><div class="citation">Prostate. 2010 May 15; 70(7):788-96.</div><p>[<a href="/pubmed/20058238/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R27">Ref list</a>]</p></div><div id="body-link-popper-R28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.<div class="authors">Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop DT, Easton DF, Stratton MR, Rahman N, UK Testicular Cancer Collaboration.</div><div class="citation">Nat Genet. 2010 Jul; 42(7):604-7.</div><p>[<a href="/pubmed/20543847/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R28">Ref list</a>]</p></div><div id="body-link-popper-R29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity.<div class="authors">Liu L, Ishihara K, Ichimura T, Fujita N, Hino S, Tomita S, Watanabe S, Saitoh N, Ito T, Nakao M</div><div class="citation">J Biol Chem. 2009 Feb 20; 284(8):5165-74.</div><p>[<a href="/pubmed/19106100/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R29">Ref list</a>]</p></div><div id="body-link-popper-R30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.<div class="authors">Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blöndal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Höiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K</div><div class="citation">Nat Genet. 2009 Feb; 41(2):221-7.</div><p>[<a href="/pubmed/19151717/" ref="reftype=pubmed&amp;article-id=3556942&amp;issue-id=218853&amp;journal-id=367&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#R30">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:15:11-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8D143EDD54CD810000000008760597&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556942%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=neoplasia&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3556942/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>